Cathy Eng Archive — Page 1 of 3
-
November 30, 2023
Journal Watch
-
June 15, 2023
New treatment option for metastatic colorectal cancer prolongs survival
Research conducted at Vanderbilt points to a new therapy is on the horizon for patients with metastatic colorectal cancer who have run out of treatment options. -
March 16, 2023
Eng stresses need for clinical trial support at cancer forum
Vanderbilt's Cathy Eng, MD, stressed the need for more patient participation and better funding for clinical trials to improve colorectal cancer treatment and outcomes during the White House Cancer Moonshot Colorectal Cancer Forum. -
March 2, 2023
Eng invited to White House Cancer Moonshot forum
Vanderbilt's Cathy Eng, MD, has been invited to participate in the White House Cancer Moonshot Colorectal Cancer Forum. -
November 7, 2022
Breakthrough Therapies
-
November 7, 2022
GI SPORE over the years
-
September 13, 2022
Patients had ‘significant and clinically meaningful improvement’ in survival in fruquintinib clinical trial
Patients with metastatic colorectal cancer who had not responded to other treatments had “significant and clinically meaningful improvement” in overall survival when treated with the oral targeted therapy fruquintinib.